Moderator: Bruce Quinn, MD, Ph.D., MBA, Principal, Bruce Quinn Associates, LLC
Panelists: Sean Scott, SVP, CBO & VP Clinical Market Development, Qiagen, Enrico Capobianco, Ph.D., Lead Scientist, Center for Computational Science – University of Miami. Martin Reese, Ph.D. Founder, President, and CEO, Fabric
Genomics, Recce Hart, Ph.D., Chief Technology Officer at Genome Medical.
More entrants provide clinical sequencing results, both for germline conditions and for cancers. Each lab must struggle to handle large amounts of clinical and genomic information, interpret results, integrate with clinical customer workflows, and differentiate from competitors. Because of the complexity and the shortage of bioinformatics staff, new entrants are emerging to outsource key bioinformatics functions. Some of these companies connect institutions, some are supporting a new era in applied clinical research, and others are trying to create a level of insight through in silico cell biology. Some
efforts go as far as providing virtual tumor boards for patients in remote locations, or integrating point of care tests with personal health records and apps. This session will consider “digital genomics” as a type of healthcare industry and forecast major trends in the next two years.